Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg
Clinical trial NCT06331715 · COMPLETED
Trial details
- NCT number
- NCT06331715
- Sponsor
- Megalabs
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-06
- Primary completion
- 2024-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.